@article {157, title = {National Survey of Clinical Pharmacy Practice in Saudi Arabia-2017-2018: Administration and Management}, journal = {PTB Reports}, volume = {6}, year = {2020}, month = {March 2020}, pages = {1-6}, type = {Research Article}, chapter = {1}, abstract = {

Objectives: In this study, we explored the national survey of clinical pharmacy practice in Saudi Arabia during 2017-2018 with an emphasis on the administration and management of pharmacy practice. Methods: This is a 4-month cross-sectional national survey of clinical pharmacy practice in Saudi Arabia. The survey consisted of two parts: the demographic information and the second part comprised a questionnaire with 51 questions divided into four domains. The domains were derived from the standards and guidelines provided by the American Society of Health-System Pharmacists (ASHP), Saudi Pharmaceutical Society (SPS), the international standard of Joint Commission of Hospital Accreditation, in addition to the local standards of Saudi Center of Healthcare Accreditation. The four domains were the clinical pharmacy administration and management, performances and activities, education and training and workload documentation. We used 5-point Likert response scale system with closeand open-ended questions to obtain the responses. The questionnaire was distributed in an electronic format to the 31 directors of pharmacies at hospitals. In this study, we conducted a national survey of clinical pharmacy practice at hospitals in Saudi Arabia on performances and activities. All data were obtained through the Survey Monkey system. Results: The survey questionnaire was distributed to 31 hospitals. The average score of the elements related to the clinical pharmacy administration was 3.32 (66.31\%). Most of the elements responded were policies and procedures of pharmacist privilege (4.00 (80.00\%)) followed by the mission of clinical pharmacy (3.87 (77.40\%)) and vision of clinical pharmacy administration (3.71 (74.20\%)). Most of the clinical pharmacy services provided for adult, pediatric, neonate and geriatric patients was for critical care, medical services and for emergency. Most of the hospitals had no satellite services assistant the clinical pharmacy services (22 (70.97\%)). The majority of the responders agreed that clinical pharmacy services improve the safety and effectiveness of patient care (27 (93.10\%)), decreases morbidity and mortality rate (23 (79.31\%)) and increases the pharmacist{\textquoteright}s role toward patient care (20 (68.97\%)). Conclusion: The elements of clinical pharmacy administration were not adequate in the KSA. Most of the hospital services received the clinical pharmacy services not exceeding 50\%. Despite the fact that the pharmacy administration has a good record of clinical pharmacy services, there are not enough resources to provide over 24-hr service. Revision of clinical pharmacy services is highly necessary in Saudi Arabia.

}, keywords = {Administration, Clinical, Management, Pharmacy, Practice, Saudi Arabia}, doi = {10.5530/PTB.2020.6.1}, author = {Yousef Ahmed Alomi and Fatimah Al-Doughan and Sultan Mohammed Al-Jarallah and Yasir Ahmed Ibrahim and Adel Mehmas Alragas and Norah Omar Bin Haidarah} } @article {158, title = {Privileges of Pharmacist in Saudi Arabia: Administration and Management}, journal = {PTB Reports}, volume = {6}, year = {2020}, month = {March 2020}, pages = {7-12}, type = {Research Article}, chapter = {7}, abstract = {

Objectives: To explore the privileges of pharmacists through the pharmacy administration and management in Saudi Arabia. Methods: This is a 4-month cross-sectional survey regarding the privileges of pharmacists in Saudi Arabia. The study consisted of two parts: the first part collected demographic information and the second part comprised a questionnaire with 28 questions divided into 4 domains. The questions were derived from previous literature and from the regulatory standards of the American Society of Health-System Pharmacists (ASHP). The four domains were as follows: privilege management and resources, pharmacist prescribing and therapeutic interchange, clinical and administration privilege and drug monitoring and healthcare education. The responses were obtained using a 5-point Likert response scale system with close- and open-ended questions. The survey questionnaire was distributed in an electronic format to the hospital{\textquoteright}s director of pharmacy of each hospital in Saudi Arabia. In this study, we analyzed pharmacist{\textquoteright}s privilege in Saudi Arabia with regard to the pharmacy administration and management. All data were obtained through the Survey Monkey system. Results: The survey was distributed to 36 hospitals. The administration-related elements of pharmacist privilege with maximum score were policies and procedures of pharmacist{\textquoteright}s privilege (3.88 (77.6\%)) followed by the vision of pharmacist privilege (3.57 (71.4\%)) and pharmacist privilege in the job description (3.56 (71.2\%)). The average score of pharmacist privilege in the hospital committees was 3.47 (69.40\%). Most of the committees having pharmacist privilege was the patient or medication safety committee (4.09 (81.8\%)) followed by the pharmacy and therapeutic committee (4.06 (81.2\%)) and quality management committee (4.06 (81.2\%)). The average score of pharmacist privilege in the teams was 3.44 (68.85\%). The majority of the teams having pharmacist privilege was antibiotics team (4.25 (85\%)) followed by anticoagulation team (3.86 (77.2\%)) and IV therapy team (3.81 (76.2\%)). Conclusion: The privileges of a pharmacists is inadequate in the Kingdom of Saudi Arabia. Future programs should target to improve the healthcare system and expand pharmacists{\textquoteright} role in the hospital practice. This might improve the pharmaceutical care services and patient outcomes and prevent drug-related problems and unnecessary economic expenditure on the healthcare practice in Saudi Arabia.

}, keywords = {Administration, Management, Pharmacist, Privileges, Saudi Arabia}, doi = {10.5530/PTB.2020.6.2}, author = {Faisal Al-Otaibi and Mohamed Soliman Imam and Randa Mansour Abdel-Sattar Ahmed and Amsha Alotaibi and Asma Alotaibi and Amal Alotaibi and Wesam Alsuwaid and Yousef Ahmed Alomi} } @article {120, title = {National Survey of Medication Safety Practice: Medication Administration at Primary Healthcare Centers/Community Pharmacies in Riyadh, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {January 2019}, pages = {28-35}, type = {Research Article}, chapter = {28}, abstract = {

Objective: To explore the national medication safety practice with emphasis on medication administration at primary healthcare centers (PHCs) and community pharmacies (CPs) in Riyadh city, Kingdom of Saudi Arabia. Methods: This is a four-month cross-sectional medication safety practice survey conducted at PHC pharmacies and CPs in Riyadh city. The survey consisted of the modified version of the Medication Safety Self-Assessment{\textregistered} for Community/Ambulatory Pharmacy from the Institute of Safe Medication Practice (ISMP). The survey consisted of a demographic section and 10 domains with 198 questions. The domains included questions on patient information; drug information; communication of drug orders and other drug information; drug labeling and packaging and nomenclature; use of devices; environmental factors; staff competency and education; patient education; quality processes; and risk management domain. In this study, we emphasized on medication administration; it is a finding from medication safety self-assessment for community/ambulatory pharmacy in Riyadh city. Results: The survey was distributed to 13 PHC pharmacies and 23 CPs. The average score of all ISMP-self assessment items of medication safety at PHCs was 2.75{\textpm}0.36 (54.94\%) (95\% CI=2.55{\textendash} 2.95; P\<0.05; range=2.04{\textendash}3.38). The average score of all ISMP-self assessment items of medication safety at CPs was 3.14{\textpm}0.42 (62.86\%) (95\% CI=2.90{\textendash}4.38; P\<0.05; range=2.40{\textendash}3.88). The average score of drug standardization, storage and distribution domain at PHCs was 2.35{\textpm}0.41 (47\%) (95\% CI=2.17{\textendash}2.53; P\<0.05; range=1.33{\textendash}3.09) and in CPs, it was 3.4{\textpm}0.54 (68\%) (95\% CI =3.16{\textendash}3.54; P\<0.05; range=2.22{\textendash}4.25). The average score of medication devices acquisition, use and monitoring domain at PHCs was 3.62{\textpm}0.14 (72.4\%) (95\% CI=3.26{\textendash}3.978; P\<0.05; range=3.45{\textendash}3.70) and in CPs, it was 2.78{\textpm}0.23 (55.6\%) (95\% CI=2.21{\textendash}3.349; P\<0.05; range=2.63-3.05). Conclusion: The medication administration safety was inadequate at PHCs while acceptable at CPs. Targeting to drug standardization, storage and distribution with emphasis on medication devices use and monitoring are highly recommended at PHCs in the Kingdom of Saudi Arabia.

}, keywords = {Administration, Community Pharmacy, Medication, Primary care centers, Riyadh, Safety, Saudi Arabia}, doi = {10.5530/PTB.2019.5.6}, author = {Yousef Ahmed Alomi and Adel Mehmas Hamdi Alragas and Manar Mohammed Alslim and Khulud Abdulrahman Alamoudi and Zainab Abdulmunem Almuallem and Rana Mohammed Alslim} }